XTX Topco’s Exagen XGN Stock Holding History

XTX Topco’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$521K	Sell	111,948 -130,337	-54%	-$491K	0.01%	2414
2026 Q1	$727K	Buy	242,285 +145,291	+150%	+$562K	0.01%	1701
2025 Q4	$590K	Buy	96,994 +69,161	+248%	+$629K	0.02%	1458
2025 Q3	$306K	Buy	27,833 +8,800	+46%	+$77.9K	0.02%	1486
2025 Q2	$133K	Buy	+19,033	New	+$116K	0.01%	1820

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

XTX Topco's XGN Position: Q2 2026 in Review

XTX Topco reduced its Exagen (XGN) stake by 54% in Q2 2026, selling an estimated $491K and leaving 111,948 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #2414.

XTX Topco first reported a position in XGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $727K in Q1 2026. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

XTX Topco held 111,948 shares of Exagen worth $521K as of Q2 2026.
XTX Topco sold 130,337 Exagen shares in Q2 2026, an estimated $491K.
Exagen made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2414 holding.
XTX Topco first reported a position in Exagen in Q2 2025 and has held it in 5 quarters since.
XTX Topco's Exagen position peaked at $727K in Q1 2026.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.